IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

ABSTRACT: This randomized phase III study compares safety and efficacy of two sequence arms in advanced colorectal cancer: irinotecan and S-1 (IRIS) followed by oxaliplatin containing regimen (arm A), or l-leucovorin (l-LV), 5-FU and oxaliplatin (mFOLFOX6) followed by irinotecan containing regimen (arm B).

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2028241 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR